In a major departure from industry practice, GlaxoSmithKline, the sixth-largest global drug maker, announced Tuesday that it will no longer hire doctors to promote its drugs. The company also will stop tying compensation for sales representatives to the number of prescriptions written for drugs they market. The changes will be made worldwide
GlaxoSmithKline To Quit Paying Doctors For Promotional Talks
The company will no longer hire doctors to promote its drugs and will stop tying drug rep pay to number of prescriptions written.